How Far Can AI Transform Drug Development?

Thu, Nov 19, 2026 · 2:00–3:30 PM IST Multipurpose Hall (Second Floor), CIDCO Auditorium & Convention Centre

About this session

Programme: DS.S3.T1: Precision Design: Leveraging AI and Predictive Analytics to Optimize Global Clinical Trials; DS.S3.T2: AI-Enabled Quality Assurance in Medical Writing Using Agent- and Prompt-Based AI Solutions; DS.S3.T3: AI in Drug Development: Balancing Automation, Autonomy and Accountability.

Speakers

Mahesh Iyer

Head, Data and Qualitative Sciences, · Bristol Myers Squibb (BMS)

Chair
Sailesh Bajpai

Solution Consultant · MEDIDATA

Speaker
Smitha Sreedharan

Associate Director, Medical Writing · IQVIA

Speaker
Santosh Shevade

Principal Data Consultant · Straive/Gramener

Speaker
Sridevi Nagarajan

Global CMC Digital Transformation Lead, Argenx & DIA AI Consortium Co-Chair, Founder & Director · AyusArogya Ltd. UK

Speaker
Manish Sharma

APAC Leader(Business CxO) - Healthcare & Health Insurance · Google

Speaker